| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,707,051,000 | 4,539,270,000 | 4,859,647,000 | 5,174,632,000 | 5,268,794,000 |
| Cost of Revenue
|
-4,161,069,000 | -4,013,367,000 | -4,326,565,000 | -4,518,447,000 | -4,659,371,000 |
|
Gross Profit
|
545,982,000 | 525,903,000 | 533,081,000 | 656,185,000 | 609,423,000 |
|
Selling, General and Administrative Expenses
|
-441,019,000 | -431,062,000 | -409,375,000 | -408,682,000 | -392,446,000 |
|
Research and Development Expenses
|
-12,176,000 | -12,176,000 | -14,607,000 | 0 | -- |
| Other Income/Expense, Operating
|
-7,563,000 | -13,993,000 | -21,463,000 | -5,439,000 | -4,138,000 |
|
Operating Income/Expenses
|
-460,758,000 | -457,231,000 | -445,445,000 | -414,121,000 | -396,584,000 |
|
Total Operating Profit/Loss
|
85,224,000 | 68,672,000 | 87,636,000 | 242,064,000 | 212,839,000 |
| Total Net Finance Income/Expense
|
-29,056,000 | -24,785,000 | -20,753,000 | -18,617,000 | -14,804,000 |
| Net Investment Income
|
68,924,000 | 54,537,000 | 29,133,000 | 56,160,000 | 23,002,000 |
| Irregular Income/Expenses
|
-1,174,000 | -11,005,000 | 48,299,000 | -11,220,000 | -10,754,000 |
|
Non-Operating Income/Expenses, Total
|
38,694,000 | 18,747,000 | 56,679,000 | 26,323,000 | -2,556,000 |
|
Pretax Income
|
123,916,000 | 87,417,000 | 144,315,000 | 268,386,000 | 210,282,000 |
|
Provision for Income Tax
|
-22,290,000 | -13,385,000 | -51,060,000 | -67,414,000 | -43,530,000 |
|
Net Income from Continuing Operations
|
101,626,000 | 74,032,000 | 93,254,000 | 200,971,000 | 166,752,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
101,626,000 | 74,032,000 | 93,254,000 | 200,971,000 | 166,752,000 |
|
Non-Controlling/Minority Interests
|
-4,342,000 | -3,867,000 | -1,386,000 | -3,550,000 | -4,130,000 |
|
Net Income after Non-Controlling/Minority Interests
|
97,284,000 | 70,165,000 | 91,868,000 | 197,421,000 | 162,622,000 |
|
Net Income Available to Common Stockholders
|
97,285,000 | 70,165,000 | 91,867,000 | 197,421,000 | 162,621,000 |
|
Diluted Net Income Available to Common Stockholders
|
97,285,000 | 70,165,000 | 91,867,000 | 197,421,000 | 162,621,000 |
| Basic EPS
|
152.92 | 110.30 | 144.43 | 323.33 | 280.68 |
| Diluted EPS
|
145.82 | 105.47 | 138.24 | 315.09 | 280.52 |
|
Basic Weighted Average Shares Outstanding
|
636,196.65 | 636,128.74 | 636,065.91 | 610,586.71 | 579,382.22 |
|
Diluted Weighted Average Shares Outstanding
|
667,398.46 | 665,260.26 | 664,547.16 | 626,554.32 | 579,712.68 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
152,972,000 | 112,202,000 | 165,068,000 | 287,003,000 | 225,086,000 |
|
EBITDA
|
112,202,000 | 112,202,000 | 422,706,000 | 561,104,000 | 494,686,000 |
|
Normalized EBITDA
|
123,207,000 | 123,207,000 | 374,407,000 | 572,324,000 | 505,440,000 |
|
Normalized Income
|
102,588,820.88 | 83,353,235 | 60,005,000 | 51,102,000 | 173,922,000 |
|
Total Unusual Items
|
1,174,000 | 11,005,000 | -48,299,000 | 11,220,000 | 10,754,000 |
3/31/2023 - 3/11/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade